Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Bio
Professional summary
Derek DiRocco is a Partner at RA Capital Management, where he works on public and private healthcare and life sciences investments. He serves as a board director for companies including Acrivon, Bambusa Therapeutics, Evommune, Forward Therapeutics, Frontier Medicines, Mineralys, Rivus, Stipple Bio, and Syntelios. He previously covered solid tumor oncology landscapes and conducted postdoctoral research at Brigham and Women's Hospital and Harvard Medical School on Wnt signaling and kidney disease.
Notable companies
Selected portfolio companies the partner has backed
Acrivon TherapeuticsBambusa TherapeuticsEvommuneForward TherapeuticsFrontier MedicinesMineralys TherapeuticsRivus PharmaceuticalsStipple BioSyntelios
Background
Career, education, and skills
Career history
- RA Capital ManagementPartnerPresent
- Brigham and Women's Hospital / Harvard Medical SchoolPostdoctoral Researcher
Education
- University of WashingtonPhD in Pharmacology
- College of the Holy CrossBA in Biology
Other partners at RA Capital Management
12 more profiles
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Allison Harrigan
Senior Director Corporate Development
RA Capital Management
Raven corporate development leader focused on biotech company creation.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.